RxDoctor Payments Data
★ My doctorsLook up a doctor →

Michael Ehrie

Ashland, KYNPI 1215920210

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $6,030 of the $8,674 with a category attached, or 69.5%. Sunovion Pharmaceuticals Inc. accounts for 86.7% of it on its own, with 16 other manufacturers making up the rest.

$8,674in general payments, 2019–2025

Across 95 payments — averaging $91.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sunovion Pharmaceuticals Inc.$8K
  • GSK$291
  • Genentech USA, Inc.$158
  • Eisai Inc.$125
  • Circassia Inc.$84
  • Mylan Specialty L.p.$70
  • plus $430 from 11 others

What the payments were for

  • Speaking & faculty fees$6,03070%
  • Travel & lodging$1,13413%
  • Food & beverage$1,49817%
  • Education$120%

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sunovion Pharmaceuticals Inc.32$7,516
GSK18$291
Genentech USA, Inc.10$158
Eisai Inc.1$125
Circassia Inc.6$84
Mylan Specialty L.p.4$70
Pulmonx Corporation1$67
Shire North American Group Inc4$65
Boehringer Ingelheim3$55
Novartis3$48
Arbor Pharmaceuticals, Inc.3$44
Covidien LP2$33
Paratek Pharmaceuticals, Inc.2$33
Philips North America LLC2$26
Pfizer1$22
Electromed, Inc.2$21
AbbVie1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →